Singapore markets open in 2 hours 7 minutes

Divi's Laboratories Limited (DIVISLAB.NS)

NSE - NSE Real-time price. Currency in INR
Add to watchlist
4,464.20-165.50 (-3.57%)
At close: 03:30PM IST
Currency in INR

Valuation measures4

Market cap (intra-day) 1.23T
Enterprise value 1.19T
Trailing P/E 76.82
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)15.67
Price/book (mrq)9.06
Enterprise value/revenue 15.16
Enterprise value/EBITDA 46.75

Trading information

Stock price history

Beta (5Y monthly) 0.37
52-week change 327.19%
S&P500 52-week change 326.25%
52-week high 34,670.00
52-week low 33,295.30
50-day moving average 34,277.13
200-day moving average 33,816.16

Share statistics

Avg vol (3-month) 3587.66k
Avg vol (10-day) 3453.64k
Shares outstanding 5265.47M
Implied shares outstanding 6266.35M
Float 8126.92M
% held by insiders 152.22%
% held by institutions 128.30%
Shares short 4N/A
Short ratio 4N/A
Short % of float 4N/A
Short % of shares outstanding 4N/A
Shares short (prior month ) 4N/A

Dividends & splits

Forward annual dividend rate 430
Forward annual dividend yield 40.65%
Trailing annual dividend rate 330.00
Trailing annual dividend yield 30.65%
5-year average dividend yield 41.14
Payout ratio 449.78%
Dividend date 3N/A
Ex-dividend date 401 Aug 2024
Last split factor 22:1
Last split date 323 Sept 2015

Financial highlights

Fiscal year

Fiscal year ends 31 Mar 2024
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 20.40%
Operating margin (ttm)27.70%

Management effectiveness

Return on assets (ttm)7.64%
Return on equity (ttm)12.15%

Income statement

Revenue (ttm)78.45B
Revenue per share (ttm)295.51
Quarterly revenue growth (yoy)18.10%
Gross profit (ttm)N/A
EBITDA 22.05B
Net income avi to common (ttm)16B
Diluted EPS (ttm)60.19
Quarterly earnings growth (yoy)67.60%

Balance sheet

Total cash (mrq)39.8B
Total cash per share (mrq)149.8
Total debt (mrq)30M
Total debt/equity (mrq)0.02%
Current ratio (mrq)7.57
Book value per share (mrq)510.80

Cash flow statement

Operating cash flow (ttm)12.61B
Levered free cash flow (ttm)1.76B